Displaying One Session

View
Room W Specialty session

State of art of TMB testing

Date
Thu, 11.04.2019
Time
11:00 - 12:30
Location
Room W
Chairs
  • M. Pérol (Lyon, CEDEX, France)
  • M. Tsao (Toronto, Ontario, Canada)
State of art of TMB testing Specialty session

TMB as predictor of immuno-oncology therapy: The science

Lecture Time
11:00 - 11:20
Speakers
  • D. Spigel (Nashville, TN, United States of America)
Session Name
State of art of TMB testing
Location
Room W, Geneva Palexpo, Geneva, Switzerland
Date
Thu, 11.04.2019
Time
11:00 - 12:30
Authors
  • D. Spigel (Nashville, TN, United States of America)
State of art of TMB testing Specialty session

TMB testing in clinic

Lecture Time
11:20 - 11:40
Speakers
  • J. Fassunke (Cologne, Germany)
Session Name
State of art of TMB testing
Location
Room W, Geneva Palexpo, Geneva, Switzerland
Date
Thu, 11.04.2019
Time
11:00 - 12:30
Authors
  • J. Fassunke (Cologne, Germany)
State of art of TMB testing Specialty session

TMB trumps PD-L1 as predictive biomarker for immuno-oncology therapy

Lecture Time
11:40 - 12:00
Speakers
  • M. Pérol (Lyon, CEDEX, France)
Session Name
State of art of TMB testing
Location
Room W, Geneva Palexpo, Geneva, Switzerland
Date
Thu, 11.04.2019
Time
11:00 - 12:30
Authors
  • M. Pérol (Lyon, CEDEX, France)
State of art of TMB testing Specialty session

PD-L1 is superior to TMB as predictive biomarker for immuno-oncology therapy

Lecture Time
12:00 - 12:20
Speakers
  • F. Hirsch (New York, CO, United States of America)
Session Name
State of art of TMB testing
Location
Room W, Geneva Palexpo, Geneva, Switzerland
Date
Thu, 11.04.2019
Time
11:00 - 12:30
Authors
  • F. Hirsch (New York, CO, United States of America)
State of art of TMB testing Specialty session

Q&A / Panel Discussion

Lecture Time
12:20 - 12:30
Session Name
State of art of TMB testing
Location
Room W, Geneva Palexpo, Geneva, Switzerland
Date
Thu, 11.04.2019
Time
11:00 - 12:30